Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...
“Minoxidil was the first drug approved for hair regrowth in men in the vertex (crown area) of the head,” trichologist and scalp therapist Bridgette Hill says, later approved for male and female use in ...
The Trump administration’s cuts to a global AIDS relief program threaten to upend rollout of a groundbreaking HIV prevention ...
The equity portion of the Abrdn Healthcare Investors Fund fell (gross of fees) but outperformed its custom benchmark over the ...
Nuage Therapeutics, a biotech company creating transformational precision therapies, has appointed Stuart Hughes as CEO and ...
Vertex' therapy takes the form of stem cell-derived human pancreatic islet cells, which secrete insulin in the body in response to rising blood glucose. The aim is to replace the pancreatic tissue ...
The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...
derives from Vertex’ near $1 billion acquisition of Semma in 2019, and has started enrolling patients in a phase 1/2 study in the US. The therapy takes the form of stem cell-derived human ...
Nigerian Tribune on MSN5d
Why we picked Anambra for People’s Assembly Initiative — Yiaga AfricaThe Senior Program Officer of Yiaga Africa, Antonia Onda, has cited a conducive environment and easy accessibility as the ...
KLP Kapitalforvaltning AS acquired a new position in WD-40 (NASDAQ:WDFC – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback